IPP-204106N
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IPP-204106N, covering 2015-02-12 to 2015-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Dose-finding Adaptive Phase I/IIa Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of IPP-204106N on Advanced Solid Tumors [Phase 1, Phase 2]